Alan B. Lancz & Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $951K | Hold |
5,124
| – | – | 0.95% | 28 |
|
|
2025
Q1 | $1.07M | Sell |
5,124
-100
| -2% | -$21K | 1.14% | 20 |
|
|
2024
Q4 | $928K | Sell |
5,224
-400
| -7% | -$71.1K | 0.94% | 22 |
|
|
2024
Q3 | $1.11M | Sell |
5,624
-150
| -3% | -$29.6K | 1.02% | 22 |
|
|
2024
Q2 | $990K | Buy |
+5,774
| New | +$990K | 0.98% | 21 |
|
|
2023
Q4 | $956K | Hold |
6,167
| – | – | 1% | 23 |
|
|
2023
Q3 | $919K | Sell |
6,167
-307
| -5% | -$45.8K | 1.04% | 21 |
|
|
2023
Q2 | $872K | Hold |
6,474
| – | – | 0.93% | 24 |
|
|
2023
Q1 | $1.03M | Hold |
6,474
| – | – | 1.07% | 19 |
|
|
2022
Q4 | $994K | Hold |
6,474
| – | – | 1% | 20 |
|
|
2022
Q3 | $869K | Hold |
6,474
| – | – | 1.03% | 21 |
|
|
2022
Q2 | $929K | Sell |
6,474
-486
| -7% | -$69.7K | 0.92% | 25 |
|
|
2022
Q1 | $1.13M | Hold |
6,960
| – | – | 1% | 23 |
|
|
2021
Q4 | $942K | Buy |
+6,960
| New | +$942K | 0.82% | 26 |
|